Trifluoroacetic acid → HCID 86727513, compound
Reaction equation
C(OC([N:8]1[CH2:11][C:10]([CH3:34])([C@@H:12]([C:14]2[CH:15]=[C:16]3[C:25](=[CH:26][C:27]=2[C:28]([F:31])([F:30])[F:29])[O:24][CH2:23][C:22]2[N:17]3[C@H:18]([CH3:33])[C:19](=[O:32])[NH:20][N:21]=2)[CH3:13])[CH2:9]1)=O)(C)(C)C.[C:35]([OH:41])([C:37]([F:40])([F:39])[F:38])=[O:36]>C(Cl)Cl>[F:38][C:37]([F:40])([F:39])[C:35]([OH:41])=[O:36].[CH3:33][C@H:18]1[N:17]2[C:22]([CH2:23][O:24][C:25]3[C:16]2=[CH:15][C:14]([C@H:12]([C:10]2([CH3:34])[CH2:9][NH:8][CH2:11]2)[CH3:13])=[C:27]([C:28]([F:29])([F:31])[F:30])[CH:26]=3)=[N:21][NH:20][C:19]1=[O:32]Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of 3-methyl-3-[(R)-1-((R)-4-methyl-3-oxo-7-trifluoromethyl-2,3,4,10-tetrahydro-9-oxa-1,2,4a-triaza-phenanthren-6-yl)-ethyl]-azetidine-1-carboxylic acid tert-butyl ester (diastereomer 1, 0.062 g, 0.128 mmol) in DCM (4 mL) was added TFA (1 mL) and the reaction mixture was stirred at ambient temperature for 1.5 h. The solvent was removed in vacuo to give (R)-4-methyl-6-[(R)-1-(3-methyl-azetidin-3-yl)-ethyl]-7-trifluoromethyl-2,10-dihydro-9-oxa-1,2,4a-triaza-phenanthren-3-one trifluoroacetic acid (Example #147-1, Enantiomer 1, 0.060 g, 94%) as a solid. 1H NMR (CD3OD-d4, 400 MHz): δ 7.46 (s, 1H), 7 (s, 1H), 4.95 (m, 1H), 4.70 (d, J=13.2 Hz, 2H), 4.3 (d, J=10.8 Hz, 1H), 3.95 (d, J=10.8 Hz, 1H), 3.65 (t, J=10.0 Hz, 2H), 3.26 (m, 1H), 1.55 (s, 3H), 1.49 (d, J=7.2 Hz, 3H), 1.44 (d, J=7.2 Hz, 3H). LC/MS (Table 1, Method 4) Rt=1.741 min; MS m/z: 383 [M+H]+. SFC (Table 1, Method 36) Rt=4.264 min.
Workup
- customThe solvent was removed in vacuo
Sources & evidence
- ORD record
- ord-dcd71c241cc944eb8a1f735af68959b7
- Source dataset
- uspto-grants-2015_08
- Patent number
- US09115151B2
Reaction notes
Loading…